Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AAV-mediated gene therapy: Advancing cardiovascular disease treatment
Huili Zhang, Zhan Qi, Biao Huang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Clinical Cardiology (2024) Vol. 5, Iss. 1, pp. 6-29
Open Access | Times Cited: 22
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease
Andrea Caporali, Maryam Anwar, Yvan Devaux, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 8, pp. 556-573
Closed Access | Times Cited: 18
Biomaterial‐based gene therapy
Yi Yu, Yijun Gao, Liming He, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 33
The heterocellular heart: identities, interactions, and implications for cardiology
Achim Lother, Peter Köhl
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 28
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases
Chujiao Lin, Matthew B. Greenblatt, Guangping Gao, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 9-10, pp. 317-328
Closed Access | Times Cited: 13
Gene therapy clinical trials worldwide to 2023—an update
Samantha L. Ginn, Mawj Mandwie, Ian E. Alexander, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 8
Closed Access | Times Cited: 12
Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina
Aurélien Leray, Pierre-Alban Lalys, Juliette Varin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116148-116148
Open Access | Times Cited: 11
AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich’s ataxia
Joshua C. Chang, Molly R. Ryan, Marie C. Stark, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 1, pp. 101193-101193
Open Access | Times Cited: 6
Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors
Levon M. Khachigian, Ramon L. Varcoe, Tuisku Suoranta, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 6, pp. 836-851
Open Access | Times Cited: 13
MicroRNAs and therapeutic potentials in acute and chronic cardiac disease
Rui Song, Li Zhang
Drug Discovery Today (2024), pp. 104179-104179
Open Access | Times Cited: 5
miR‐207 Suppresses the Progression of SiO2‐Induced Pulmonary Fibrosis by Targeting Smad3 to Regulate the TGF‐β1/Smad3 Signaling Pathway in C57BL/6 Mice
Jia‐hui Zhao, Shuang Li, Shu‐ling Du, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy
Duo Li, Minli Linghu, Jisen Tang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Therapeutic silencing of lncRNA RMST alleviates cardiac fibrosis and improves heart function after myocardial infarction in mice and swine
Teng Ma, Fan Qiu, Yanshan Gong, et al.
Theranostics (2023) Vol. 13, Iss. 11, pp. 3826-3843
Open Access | Times Cited: 11
AAV-mediated gene therapy for sialidosis
Diantha van de Vlekkert, Huimin Hu, Jason A. Weesner, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2094-2112
Open Access | Times Cited: 4
Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy
Yanan Wang, Haibin Jiang, Mopu Li, et al.
Gene (2024) Vol. 927, pp. 148733-148733
Closed Access | Times Cited: 4
MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway
Yimin Xue, Tianjiao Song, Jun Ke, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116173-116173
Closed Access | Times Cited: 2
Serotype-agnostic affinity purification of adeno-associated virus (AAV) via peptide-functionalized chromatographic resins
Shriarjun Shastry, Eduardo Barbieri, Arianna Minzoni, et al.
Journal of Chromatography A (2024) Vol. 1734, pp. 465320-465320
Closed Access | Times Cited: 2
A Novel and Simplified Anion Exchange Flow‐Through Polishing Approach for the Separation of Full From Empty Adeno‐Associated Virus Capsids
Frederik Meierrieks, Alisa Weltken, Karl Pflanz, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 2
Long-Term Survival and Myocardial Function Following Systemic Delivery of Delandistrogene Moxeparvovec in DMDMDX Rats
Stephen Baine, Chris Wier, Luke R. Lemmerman, et al.
Human Gene Therapy (2024)
Closed Access | Times Cited: 2
AAV delivery strategy with mechanical support for safe and efficacious cardiac gene transfer in swine
Renata Mazurek, Serena Tharakan, Spyros A. Mavropoulos, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Casein kinase 2 activity is a host restriction factor for AAV transduction
Izabela Kraszewska, Katarzyna Sarad, Kalina Andrysiak, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 84-102
Open Access | Times Cited: 5
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders
Pranay Wal, Namra Aziz, Chetan Pratap Singh, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 5, pp. 356-376
Closed Access | Times Cited: 1
Insight into the structure, function and the tumor suppression effect of gasdermin E
Yuge Long, Xiaoyuan Jia, Liang Chu
Biochemical Pharmacology (2024) Vol. 226, pp. 116348-116348
Closed Access | Times Cited: 1
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8464-8498
Open Access | Times Cited: 1
Gene therapy of cardiomyopathies: opportunities and current perspectives
А. В. Лавров, E. V. Zaklyazminskaya
Clinical and Experimental Surgery Petrovsky journal (2023) Vol. 11, Iss. 1, pp. 32-46
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top